Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT01058707 |
Title | Dose Escalation Study of MLN0128 in Subjects With Advanced Malignancies |
Recruitment | Completed |
Gender | both |
Phase | Phase I |
Variant Requirements | No |
Sponsors | Millennium Pharmaceuticals, Inc. |
Indications | |
Therapies | |
Age Groups: | adult |
Covered Countries | USA | ESP |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
Scottsdale | Arizona | United States | Details | |||
Los Angeles | California | United States | Details | |||
Miami | Florida | United States | Details | |||
Sarasota | Florida | United States | Details | |||
Indianapolis | Indiana | United States | Details | |||
Boston | Massachusetts | United States | Details | |||
Ann Arbor | Michigan | United States | Details | |||
Detroit | Michigan | United States | Details | |||
Buffalo | New York | United States | Details | |||
New York | New York | United States | Details | |||
Cleveland | Ohio | United States | Details | |||
Oklahoma City | Oklahoma | United States | Details | |||
Philadelphia | Pennsylvania | United States | Details | |||
Nashville | Tennessee | United States | Details | |||
Barcelona | Spain | Details | ||||
Valencia | Spain | Details |